Anti-HLA antibodies in patients who underwent haplo-HCT
| Number . | Graft type . | Anti-HLA antibodies . | Donor-specific anti-HLA antibodies . | Outcome . | ||
|---|---|---|---|---|---|---|
| Class I . | Class II . | Class I . | Class II . | |||
| 1 | CD34+ selected* | No | No | No | No | Stable |
| 2 | CD34+ selected | No | No | No | No | Rejection |
| 3 | CD34+ selected | No | No | No | No | Rejection |
| 4 | CD34+ selected | No | No | No | No | Stable |
| 5 | CD34+ selected | No | Yes | No | No | Rejection |
| 6 | CD34+ selected | No | Yes | No | No | Stable |
| 7 | CD34+ selected | No | No | No | No | Stable |
| 8 | CD34+ selected | Yes | Yes | A24; MFI = 21 520 | No | Rejection |
| 9 | CD34+ selected | Yes | No | B57; MFI = 777 | No | Rejection |
| 10 | CD34+ selected | No | No | No | No | Stable |
| 11 | CD34+ selected | No | No | No | No | Rejection |
| 12 | CD34+ selected | No | No | No | No | Stable |
| 13 | CD34+ selected | Yes | Yes | A23; MFI=16891 | DQ2; MFI = 2358 | Rejection |
| B45; MFI = 21 993 | ||||||
| 14 | TCRαβ depleted† | No | No | No | No | Stable |
| 15 | TCRαβ depleted | Yes | Yes | No | No | Rejection |
| 16 | TCRαβ depleted | No | No | No | No | Stable |
| 17 | TCRαβ depleted | No | No | No | No | Stable |
| 18 | TCRαβ depleted | No | No | No | No | Stable |
| Number . | Graft type . | Anti-HLA antibodies . | Donor-specific anti-HLA antibodies . | Outcome . | ||
|---|---|---|---|---|---|---|
| Class I . | Class II . | Class I . | Class II . | |||
| 1 | CD34+ selected* | No | No | No | No | Stable |
| 2 | CD34+ selected | No | No | No | No | Rejection |
| 3 | CD34+ selected | No | No | No | No | Rejection |
| 4 | CD34+ selected | No | No | No | No | Stable |
| 5 | CD34+ selected | No | Yes | No | No | Rejection |
| 6 | CD34+ selected | No | Yes | No | No | Stable |
| 7 | CD34+ selected | No | No | No | No | Stable |
| 8 | CD34+ selected | Yes | Yes | A24; MFI = 21 520 | No | Rejection |
| 9 | CD34+ selected | Yes | No | B57; MFI = 777 | No | Rejection |
| 10 | CD34+ selected | No | No | No | No | Stable |
| 11 | CD34+ selected | No | No | No | No | Rejection |
| 12 | CD34+ selected | No | No | No | No | Stable |
| 13 | CD34+ selected | Yes | Yes | A23; MFI=16891 | DQ2; MFI = 2358 | Rejection |
| B45; MFI = 21 993 | ||||||
| 14 | TCRαβ depleted† | No | No | No | No | Stable |
| 15 | TCRαβ depleted | Yes | Yes | No | No | Rejection |
| 16 | TCRαβ depleted | No | No | No | No | Stable |
| 17 | TCRαβ depleted | No | No | No | No | Stable |
| 18 | TCRαβ depleted | No | No | No | No | Stable |